Electroceuticals, also known as bioelectric medicine, offer an alternative to drug-based remedies and are used in treating various ailments through neurostimulation. The global electroceuticals market is projected to grow significantly due to factors like rising chronic disease prevalence, increased investment in advanced devices, and government support. Major players like GSK PLC and Microsoft Corp. have invested heavily in R&D programs, expecting a surge in market growth. The growing geriatric population, with a higher risk of neurological diseases, is another key factor contributing to the market’s expansion. Significant investments in R&D by companies like Medtronic PLC and GlaxoSmithKline PLC, along with funding from NIH, are expected to drive the future growth of the electroceuticals industry.
Read more from wfmz.com
